Cargando…

20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report

BACKGROUND: We developed a simple and new insulin resistance index derived from a glucose clamp and a meal tolerance test (MTT) in Japanese patients with type 2 diabetes mellitus. METHODS: Fifteen patients [mean age: 53 years, fasting plasma glucose (FPG) 7.7 mmol/L, HbA1c 7.1% (54 mmol/mol), body m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohkura, Tsuyoshi, Shiochi, Hideki, Fujioka, Youhei, Sumi, Keisuke, Yamamoto, Naoya, Matsuzawa, Kazuhiko, Izawa, Shoichiro, Kinoshita, Hiroshi, Ohkura, Hiroko, Kato, Masahiko, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608161/
https://www.ncbi.nlm.nih.gov/pubmed/23339473
http://dx.doi.org/10.1186/1475-2840-12-21
_version_ 1782264196270915584
author Ohkura, Tsuyoshi
Shiochi, Hideki
Fujioka, Youhei
Sumi, Keisuke
Yamamoto, Naoya
Matsuzawa, Kazuhiko
Izawa, Shoichiro
Kinoshita, Hiroshi
Ohkura, Hiroko
Kato, Masahiko
Taniguchi, Shin-ichi
Yamamoto, Kazuhiro
author_facet Ohkura, Tsuyoshi
Shiochi, Hideki
Fujioka, Youhei
Sumi, Keisuke
Yamamoto, Naoya
Matsuzawa, Kazuhiko
Izawa, Shoichiro
Kinoshita, Hiroshi
Ohkura, Hiroko
Kato, Masahiko
Taniguchi, Shin-ichi
Yamamoto, Kazuhiro
author_sort Ohkura, Tsuyoshi
collection PubMed
description BACKGROUND: We developed a simple and new insulin resistance index derived from a glucose clamp and a meal tolerance test (MTT) in Japanese patients with type 2 diabetes mellitus. METHODS: Fifteen patients [mean age: 53 years, fasting plasma glucose (FPG) 7.7 mmol/L, HbA1c 7.1% (54 mmol/mol), body mass index 26.8 kg/m(2)] underwent a MTT and a glucose clamp. Participants were given a test meal (450 kcal). Plasma glucose and insulin were measured at 0 (fasting), 30, 60, 120, and 180 min. Serum C-peptide immunoreactivity (CPR) was measured at 0 (fasting; F-CPR) and 120 min. Homeostasis model assessment of insulin resistance (HOMA-IR) and insulin sensitivity indices (ISI) were calculated from the MTT results. The glucose infusion rate (GIR) was measured during hyperinsulinemic–euglycemic glucose clamps. RESULTS: The mean GIR in all patients was 5.8 mg·kg(–1)·min(–1). The index 20/(F-CPR × FPG) was correlated strongly with GIR (r = 0.83, P < 0.0005). HOMA-IR (r = −0.74, P < 0.005) and ISI (r = 0.66, P < 0.01) were also correlated with GIR. In 10 patients with mild insulin resistance (GIR 5.0–10.0 mg·kg(–1)·min(–1)), 20/(F-CPR × FPG) was very strongly correlated with GIR (r = 0.90, P < 0.0005), but not with HOMA-IR and ISI (r = −0.49, P = 0.15; r = 0.20, P = 0.56, respectively). In patients with mild insulin resistance, plasma adiponectin (r = 0.65, P < 0.05), but not BMI or waist circumstance, was correlated with GIR. CONCLUSIONS: 20/(F-CPR × FPG) is a simple and effective index of insulin resistance, and performs better than HOMA-IR and ISI in Japanese patients with type 2 diabetes mellitus. Our results suggest that 20/(F-CPR × FPG) is a more effective index than HOMA-IR in Japanese patients with mild insulin resistance.
format Online
Article
Text
id pubmed-3608161
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36081612013-03-27 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report Ohkura, Tsuyoshi Shiochi, Hideki Fujioka, Youhei Sumi, Keisuke Yamamoto, Naoya Matsuzawa, Kazuhiko Izawa, Shoichiro Kinoshita, Hiroshi Ohkura, Hiroko Kato, Masahiko Taniguchi, Shin-ichi Yamamoto, Kazuhiro Cardiovasc Diabetol Original Investigation BACKGROUND: We developed a simple and new insulin resistance index derived from a glucose clamp and a meal tolerance test (MTT) in Japanese patients with type 2 diabetes mellitus. METHODS: Fifteen patients [mean age: 53 years, fasting plasma glucose (FPG) 7.7 mmol/L, HbA1c 7.1% (54 mmol/mol), body mass index 26.8 kg/m(2)] underwent a MTT and a glucose clamp. Participants were given a test meal (450 kcal). Plasma glucose and insulin were measured at 0 (fasting), 30, 60, 120, and 180 min. Serum C-peptide immunoreactivity (CPR) was measured at 0 (fasting; F-CPR) and 120 min. Homeostasis model assessment of insulin resistance (HOMA-IR) and insulin sensitivity indices (ISI) were calculated from the MTT results. The glucose infusion rate (GIR) was measured during hyperinsulinemic–euglycemic glucose clamps. RESULTS: The mean GIR in all patients was 5.8 mg·kg(–1)·min(–1). The index 20/(F-CPR × FPG) was correlated strongly with GIR (r = 0.83, P < 0.0005). HOMA-IR (r = −0.74, P < 0.005) and ISI (r = 0.66, P < 0.01) were also correlated with GIR. In 10 patients with mild insulin resistance (GIR 5.0–10.0 mg·kg(–1)·min(–1)), 20/(F-CPR × FPG) was very strongly correlated with GIR (r = 0.90, P < 0.0005), but not with HOMA-IR and ISI (r = −0.49, P = 0.15; r = 0.20, P = 0.56, respectively). In patients with mild insulin resistance, plasma adiponectin (r = 0.65, P < 0.05), but not BMI or waist circumstance, was correlated with GIR. CONCLUSIONS: 20/(F-CPR × FPG) is a simple and effective index of insulin resistance, and performs better than HOMA-IR and ISI in Japanese patients with type 2 diabetes mellitus. Our results suggest that 20/(F-CPR × FPG) is a more effective index than HOMA-IR in Japanese patients with mild insulin resistance. BioMed Central 2013-01-22 /pmc/articles/PMC3608161/ /pubmed/23339473 http://dx.doi.org/10.1186/1475-2840-12-21 Text en Copyright ©2013 Ohkura et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Ohkura, Tsuyoshi
Shiochi, Hideki
Fujioka, Youhei
Sumi, Keisuke
Yamamoto, Naoya
Matsuzawa, Kazuhiko
Izawa, Shoichiro
Kinoshita, Hiroshi
Ohkura, Hiroko
Kato, Masahiko
Taniguchi, Shin-ichi
Yamamoto, Kazuhiro
20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report
title 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report
title_full 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report
title_fullStr 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report
title_full_unstemmed 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report
title_short 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report
title_sort 20/(fasting c-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608161/
https://www.ncbi.nlm.nih.gov/pubmed/23339473
http://dx.doi.org/10.1186/1475-2840-12-21
work_keys_str_mv AT ohkuratsuyoshi 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT shiochihideki 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT fujiokayouhei 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT sumikeisuke 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT yamamotonaoya 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT matsuzawakazuhiko 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT izawashoichiro 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT kinoshitahiroshi 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT ohkurahiroko 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT katomasahiko 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT taniguchishinichi 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport
AT yamamotokazuhiro 20fastingcpeptidefastingplasmaglucoseisasimpleandeffectiveindexofinsulinresistanceinpatientswithtype2diabetesmellitusapreliminaryreport